Data as of Aug 29
| +0.46 / +3.72%|
The 4 analysts offering 12-month price forecasts for Genocea Biosciences Inc have a median target of 27.00, with a high estimate of 40.00 and a low estimate of 22.00. The median estimate represents a +110.77% increase from the last price of 12.81.
The current consensus among 4 polled investment analysts is to Buy stock in Genocea Biosciences Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.